Officers, Board and Executive Committee

ARM Officers:

Robert Preti (ARM Officer: Chairman)
President & CEO 
Hitachi Chemical Advanced Therapeutics Solutions

General Manager
Hitachi Chemical Regenerative Medicine Business Sector 

Matt Patterson (ARM Officer: Vice Chairman)
President & CEO 
Audentes Therapeutics

Martha Rook (ARM Officer: Secretary)
Head of Gene Editing and Novel Modalities
MilliporeSigma / EMD Millipore

Rahul Aras (ARM Officer: Treasurer) 
Co-Founder, President & CEO 
Juventas Therapeutics

ARM Board of Directors:

Zami Aberman
Chairman & Co-CEO
Pluristem Therapeutics

Rahul Aras (ARM Officer: Treasurer) 
Co-Founder, President and Chief Executive Officer
Juventas Therapeutics

Usman Azam
Chief Executive Officer
Tmunity Therapeutics

Bob Azelby
Chief Commercial Officer
Juno Therapeutics

Ron Bartek
President & Co-Founder
Friedreich's Ataxia Research Alliance

Nessan Bermingham
CEO, President & Founder
Intellia Therapeutics

Eduardo Bravo

Chief Executive Officer 
TiGenix

Samuele Butera
Global Cell & Gene Therapies Business Leader
Novartis Oncology

Amy Butler
Vice President and General Manager Cell Biology
Thermo Fisher Scientific

Sarah Creviston

Vice President & Global Head for Patient Advocacy & Public Affairs

Shire

Deborah Dean

Executive Vice President & Chief Compliance Officer

MiMedx

Flagg Flanagan
Chairman & Chief Executive Director 
DiscGenics

Michael Hunt

Chief Financial Officer

ReNeuron

Dena Ladd
Executive Director 
Missouri Cures

Paul Laikind

President & CEO

ViaCyte

Bruce Levine

Founding Director, Clinical Cell and Vaccine Production Facility

Abramson Cancer Center, University of Pennsylvania

Bill Lundberg

Senior Adviser & Head, Scientific Advisory Board

CRISPR Therapeutics

Michael May
President & Chief Executive Officer 
Centre for Commercialization of Regenerative Medicine (CCRM)

Emile Nuwaysir
President & Chief Executive Officer
BlueRock Therapeutics

Matt Patterson (ARM Officer: Vice Chairman)
President &  Chief Executive Officer 
Audentes Therapeutics

Robert Preti (ARM Officer: Chairman)
President & 
 Chief Executive Officer 
Hitachi Chemical Advanced Therapeutics Solutions

General Manager
Hitachi Chemical Regenerative Medicine Business Sector 

Isabelle Riviere
Director, Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center

Martha Rook (ARM Officer: Secretary)
Head of Gene Editing and Novel Modalities
MilliporeSigma / EMD Millipore

Sanjaya Sighn

Vice President and Global Head

Janssen Bio Therapeutics

Donna Skerrett

Chief Medical Officer 
Mesoblast Limited

Bob Smith 

Senior Vice President, Global Gene Therapy Business 
Pfizer

Joe Tarnowski
Senior Vice President, Cell & Gene Therapy Platform
GSK

Keith Thompson
Chief Executive Officer 
Cell
& Gene Therapy Catapult
Gil Van Bokkelen
Co-Founder, President & CEO
Athersys

Phil Vanek
General Manager, Cell Therapy Growth Strategies
GE Healthcare LIfe Sciences

Jeffrey Walsh

Chief Financial and Strategy Officer
bluebird bio

Susan Washer
President & CEO
AGCT

Jason Wertheim

Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute

Northwestern University
Claudia Zylberberg
Founder & CEO
Akron Biotech

ARM Executive Committee:

Rahul Aras (ARM Officer: Treasurer) 
Co-Founder, President & CEO 
Juventas Therapeutics

Eduardo Bravo
Chief Executive Officer 
TiGenix

Sarah Creviston

Vice President & Global Head for Patient Advocacy & Public Affairs

Shire

Michael Hunt

Chief Financial Officer

ReNeuron

Bill Lundberg
Senior Adviser & Head, Scientific Advisory Board
CRISPR Therapeutics

Michael May
President & Chief Executive Officer 
Centre for Commercialization of Regenerative Medicine (CCRM)

Matt Patterson (ARM Officer: Vice Chairman)
President & CEO 
Audentes Therapeutics

Robert Preti (ARM Officer: Chairman)
President & CEO 
Hitachi Chemical Advanced Therapeutics Solutions

General Manager
Hitachi Chemical Regenerative Medicine Business Sector 

Martha Rook (ARM Officer: Secretary)

Head of Gene Editing and Novel Modalities

MilliporeSigma / EMD Millipore
Phil Vanek
General Manager, Cell Therapy Growth Strategy
GE Healthcare LIfe Sciences

Jason Wertheim

Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute

Northwestern University